Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
-Can increase development of lean body mass -May reduce body fat through lipolysis
It was identified through a medicinal chemistry programme at the University of Texas Health Science Center as the lead NNMT inhibitor candidate among a series of 1-methylquinolinium analogues bearing primary amine substitutions, selected for its combination of high passive membrane permeability (confirmed in PAMPA assays), high active transport membrane permeability (confirmed in bidirectional Caco-2 cell assays), potent NNMT inhibitory activity, and high selectivity including confirmed absence of inhibitory effects on related SAM-dependent methyltransferases or enzymes in the NAD+ salvage pathway
Unsatisfying adherence to medical treatment is a known problem in clinical obesity (46), hence weekly injections is theoretically a preferable treatment regimen over daily administration
Sun K, Wu Z, Ji Y, Wu G
Semaglutide is a medication that was originally developed to treat type 2 diabetes but has gained popularity for its effectiveness in aiding weight loss
US$ 27.71
US$ 25.92
US$ 26.76
US$ 27.86
US$ 24.07
US$ 24.08
US$ 23.82
